Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/1992
04/08/1992EP0479479A1 Imadazole angiotensin II antagonists incorporating acidic functional groups
04/08/1992EP0479210A2 GIP analogues and use thereof
04/08/1992EP0479177A2 4- or 5-substituted pyridine-2-carboxylic acids, process for their preparation and their use as medicaments
04/08/1992EP0478792A1 High-protein high-viscosity alimentary food composition
04/08/1992EP0478787A1 Novel process for producing benzoic acid derivative
04/08/1992EP0478775A1 Peptide derivatives
04/08/1992EP0478558A1 An improved process for the preparation of substituted isoflavone derivatives.
04/08/1992CN1016169B Process for preparing imidazole derivatives
04/07/1992US5102905 For treating side effects of diabetes and galactosemia
04/07/1992US5102900 Imidazoles useful as antiatherosclerotic agents
04/07/1992US5102895 Novel vitamin e derivatives and process for the production thereof
04/07/1992US5102894 Antihyporic, antiischemic, antiepileptic agents
04/07/1992US5102888 Quinoline type mevalonolactones useful for treating hyperlipidemia and related diseases
04/07/1992US5102886 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
04/07/1992CA1298536C Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficiency
04/02/1992WO1992005446A1 Cloned glutamic acid decarboxylase
04/02/1992WO1992005180A1 Heterocyclic compounds
04/02/1992WO1992005169A1 (2-thienyl) alkylamine derivatives having neuroprotective properties
04/02/1992WO1992005160A1 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts
04/02/1992CA2052517A1 Imidazole angiotensin ii antagonists incorporating acidic functional groups
04/02/1992CA2052510A1 4- or 5-substituted pyridine-2-carboxylic acids, a process for the preparation thereof and the use thereof as pharmaceuticals
04/01/1992EP0478292A1 Heterocyclic compounds
04/01/1992EP0477885A2 Parathyroid hormone derivatives
04/01/1992EP0477778A2 Benzene, pyridine and pyrimidine derivative
04/01/1992EP0477552A1 Use of 10-membered ring lactones as lipid regulators
04/01/1992EP0477195A1 Suramin type compounds and angiostatic steroids to inhibit angiogenesis
04/01/1992CN1059909A Carbocyclic adenosine analogs useful as immunosuppressants
03/1992
03/31/1992US5100894 Open chain rifamycin derivatives
03/31/1992CA1298309C Benzocycloheptene derivatives
03/31/1992CA1298201C Method and compositions for treating obesity, depression, drug abuse and narcolepsy
03/29/1992CA2046468A1 Alpha-glucosidase inhibitor, pradimicin q
03/28/1992CA2052287A1 Tricyclic heterocyclic compounds, their production and use
03/27/1992CA2051261A1 Cardiopulmonary bypass and organ transplant using a potassium channel activator
03/26/1992CA2052191A1 Benzene, pyridine and pyrimidine derivative
03/25/1992WO1992004899A1 Methods
03/25/1992EP0476646A1 Calcium uptake inhibitors
03/25/1992EP0476493A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
03/25/1992EP0172880B1 Use of long chain and medium chain triglycerides
03/25/1992CN1059722A 3-aryl-4(3h) quinazolinone cck antagonists and pharmaceutical formulations thereof
03/25/1992CA2092177A1 Methods
03/24/1992US5098930 Heterocyclic derivatives
03/24/1992US5098928 Antilipemic agents and treatment of arteriosclerosis
03/24/1992US5098910 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
03/19/1992WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM
03/19/1992WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
03/19/1992WO1992004334A1 Compounds
03/19/1992WO1992004316A1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them
03/19/1992WO1992004038A1 Pro-drugs for cck antagonists
03/19/1992WO1992004033A1 Methods for inhibiting rejection of transplanted tissue
03/19/1992WO1992003925A1 Treatment process for promoting weight loss employing a substituted δ5-androstene
03/19/1992WO1991019704A3 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
03/19/1992WO1991019692A3 Calcium citrate malate composition
03/19/1992DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them
03/19/1992CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds
03/19/1992CA2090759A1 Treatment process for promoting weight loss employing a substituted 5-androstene
03/18/1992WO1992005163A1 5-trifluoroacylamino-2-aryl oxazoles
03/18/1992EP0475896A1 Polycyclic compounds
03/18/1992EP0475895A1 Acyl derivatives of rifamycins and their use as medicaments
03/18/1992EP0475894A1 Gemfibrozil formulations
03/18/1992EP0475755A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
03/18/1992EP0475706A1 Novel squalene synthetase inhibitors
03/18/1992EP0475413A2 Carbocyclic nucleoside analogs useful as immunosuppressants
03/18/1992EP0475411A1 Novel carbocyclic adenosine analogs useful as immunosuppressants
03/18/1992EP0475148A1 Pravastatin alone or in combination with a fibric acid derivative for preventing onset of or treating type III hyperlipoproteinemia
03/18/1992EP0474733A1 Antihyperlipidemic and antiatherosclerotic urea compounds.
03/18/1992EP0198901B1 Method for preparing 1alpha-hydroxyvitamin d compounds
03/18/1992CN1059522A Stabilization and recovery method for to cotrienol and to copherol products
03/18/1992CN1059517A Acetamide derivatives
03/18/1992CA2090857A1 5-trifluoroacylamino-2-aryloxazoles 2-aryl-5-trifluoroacylaminooxazoles
03/17/1992US5097023 α-glucosidase inhibitors
03/17/1992US5096921 Organic compounds
03/17/1992US5096918 Aldose reductase inhibitors, diabetes, galactosemia
03/17/1992US5096914 Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
03/17/1992US5096713 Retinoic esters of l-cladinose, process for their preparation and their use in human of veterinary medicine and in cosmetic compositions
03/17/1992CA1297410C Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
03/15/1992CA2051229A1 Hypocholesterolemic unsymmetrical dithiol ketals
03/15/1992CA2050514A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
03/14/1992CA2050994A1 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof
03/14/1992CA2050739A1 Squalene synthetase inhibitors
03/12/1992DE4028398A1 Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung Phenylethanolamine, pharmaceutical compositions containing them and methods for their manufacture
03/11/1992WO1992004321A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
03/11/1992WO1992004040A1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
03/11/1992EP0474358A2 Use of conduritol to inhibit an increase in blood sugar level
03/11/1992EP0474291A1 HMG-COA reductase inhibitor metabolites
03/11/1992EP0474109A1 New 5-benzyl-substituted benzimidazolin-2-thion derivatives and process for their preparation
03/11/1992EP0473626A1 New diphosphonic acid derivatives, process for producing them and drugs containing them.
03/11/1992EP0466768A4 Short-chain triglycerides
03/11/1992CA2091257A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity
03/10/1992US5095115 Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone
03/10/1992CA1297035C Chewable, non-gritty calcium citrate tablet
03/10/1992CA1297034C Liquid calcium supplementation from readily soluble mixtures of calciumcompound and citric acid
03/07/1992CA2050730A1 Spiro (4.5) decane derivatives, method for preparing them and pharmaceutical compounds containing them
03/05/1992WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
03/05/1992WO1992003420A1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties
03/05/1992WO1992003414A1 Novel vitamin d analogues
03/05/1992WO1992003155A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
03/05/1992WO1992003154A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients
03/05/1992WO1992003146A1 Therapeutically active mixture of glutathion and anthocyan compounds
03/05/1992WO1992003130A1 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
03/05/1992WO1991019707A3 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones